FTC sues big pharmacy advantage administrators in excess of insulin prices The company brought action in opposition to Caremark, Specific Scripts and Optum Rx, arguing their “anticompetitive and unfair” rebating practices “artificially inflated” the record price of daily life-conserving insulin prescription drugs. Sanders quickly condemned the go in a statement https://daveshotchickennutrition07406.techionblog.com/30650518/what-does-healthcare-news-mean